GeneDx Holdings Corp. Costs and Expenses, Related Party
GeneDx Holdings Corp. (WGS) reported Costs and Expenses, Related Party of $1.05 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpensesRelatedParty · last filed 2023-08-08
- GeneDx Holdings Corp. costs and expenses, related party for the quarter ending 2023-06-30 was $1.05M, a 39.23% decline year-over-year.
- GeneDx Holdings Corp. costs and expenses, related party for the quarter ending 2023-03-31 was $1.75M, a 36.06% increase year-over-year.
- GeneDx Holdings Corp. costs and expenses, related party for the quarter ending 2022-12-31 was $1.60M, a 24.78% decline year-over-year.
- GeneDx Holdings Corp. costs and expenses, related party for the quarter ending 2022-09-30 was $1.70M, a 100.35% increase year-over-year.
- GeneDx Holdings Corp. costs and expenses, related party for fiscal 2022 was $6.31M, a 11.54% increase from fiscal 2021.
- GeneDx Holdings Corp. costs and expenses, related party for fiscal 2021 was $5.66M, a 39.77% decline from fiscal 2020.
- GeneDx Holdings Corp. costs and expenses, related party for fiscal 2020 was $9.39M, a 0.60% decline from fiscal 2019.
- GeneDx Holdings Corp. costs and expenses, related party for fiscal 2019 was $9.45M.
| Period end | Costs and Expenses, Related Party 3 month | Costs and Expenses, Related Party 6 month | Costs and Expenses, Related Party 9 month | Costs and Expenses, Related Party 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.05M 10-Q · filed 2023-08-08 | $2.80M 10-Q · filed 2023-08-08 | $4.40M derived: sum of 3 quarters · filed 2023-08-08 | $6.10M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $1.75M 10-Q · filed 2023-05-09 | $3.35M derived: sum of 2 quarters · filed 2023-05-09 | $5.04M derived: sum of 3 quarters · filed 2023-05-09 | $6.78M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.30M derived: sum of 2 quarters · filed 2023-03-16 | $5.03M derived: sum of 3 quarters · filed 2023-08-08 | $6.31M 10-K · filed 2023-03-16 |
| 2022-09-30 | $1.70M 10-Q · filed 2022-11-14 | $3.43M derived: sum of 2 quarters · filed 2023-08-08 | $4.71M 10-Q · filed 2022-11-14 | $6.84M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | $1.73M 10-Q · filed 2023-08-08 | $3.02M 10-Q · filed 2023-08-08 | $5.14M derived: sum of 3 quarters · filed 2023-08-08 | $5.99M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.28M 10-Q · filed 2023-05-09 | $3.41M derived: sum of 2 quarters · filed 2023-05-09 | $4.26M derived: sum of 3 quarters · filed 2023-05-09 | $5.15M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.13M 10-K · filed 2022-03-14 | $2.97M derived: sum of 2 quarters · filed 2022-11-14 | $3.86M derived: sum of 3 quarters · filed 2022-11-14 | $5.66M 10-K · filed 2023-03-16 |
| 2021-09-30 | $847.00K 10-Q · filed 2022-11-14 | $1.74M derived: sum of 2 quarters · filed 2022-11-14 | $3.53M 10-Q · filed 2022-11-14 | $6.69M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $888.00K 10-Q · filed 2022-08-15 | $2.69M 10-Q · filed 2022-08-15 | $5.84M derived: sum of 3 quarters · filed 2022-08-15 | $7.77M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.80M 10-Q · filed 2022-05-12 | $4.95M derived: sum of 2 quarters · filed 2022-05-12 | $6.89M derived: sum of 3 quarters · filed 2022-05-12 | $9.00M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $3.16M 10-K · filed 2022-03-14 | $5.09M derived: sum of 2 quarters · filed 2022-03-14 | $7.20M derived: sum of 3 quarters · filed 2022-03-14 | $9.39M 10-K · filed 2023-03-16 |
| 2020-09-30 | $1.93M 10-K · filed 2022-03-14 | $4.04M derived: sum of 2 quarters · filed 2022-03-14 | $6.24M derived: sum of 3 quarters · filed 2022-03-14 | |
| 2020-06-30 | $2.11M 10-K · filed 2022-03-14 | $4.31M derived: sum of 2 quarters · filed 2022-03-14 | ||
| 2020-03-31 | $2.19M 10-K · filed 2022-03-14 | |||
| 2019-12-31 | $9.45M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |